Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Cystic Fibrosis
|
2015
|
NHLBI
|
5UM1HL119073-02
|
6747
|
Ancillary Study 1
|
GOSS, CHRISTOPHER
|
UNIVERSITY OF WASHINGTON
|
WA
|
$1,853,439
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI103003-03
|
|
Pseudomonas detection and metabolism of sphingosine
|
WARGO, MATTHEW
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$274,500
|
Cystic Fibrosis
|
2015
|
NICHD
|
5R01HD064638-05
|
|
A longitudinal study of parent-child collaboration in CF and type 1 diabetes
|
MILLER, VICTORIA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$347,039
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL105470-04
|
|
Improving Inhaled Drug Delivery with Self-dispersing Liquids
|
GAROFF, STEPHEN
|
CARNEGIE-MELLON UNIVERSITY
|
PA
|
$468,886
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI097511-03
|
|
Pseudomonas biofilms and immunity
|
WOZNIAK, DANIEL
|
OHIO STATE UNIVERSITY
|
OH
|
$385,431
|
Cystic Fibrosis
|
2015
|
NCI
|
5R01CA172595-03
|
|
Regional Quantification of Lung Function in Cystic Fibrosis using Xe129 MRI
|
MATA, JAIME
|
UNIVERSITY OF VIRGINIA
|
VA
|
$318,025
|
Cystic Fibrosis
|
2015
|
NIGMS
|
5R01GM095959-04
|
|
Combined multiscale modeling and experimental study of bacterial swarming
|
ALBER, MARK
|
UNIVERSITY OF NOTRE DAME
|
IN
|
$288,800
|
Cystic Fibrosis
|
2015
|
NEI
|
5R01EY019470-06
|
|
Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution
|
DARTT, DARLENE
|
SCHEPENS EYE RESEARCH INSTITUTE
|
MA
|
$499,814
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5K23HL114883-02
|
|
Airway Microbiome in Cystic Fibrosis Pulmonary Exacerbations
|
ZEMANICK, EDITH
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$136,890
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI105013-02
|
|
Control of fimbrial gene expression in Pseudomonas aeruginosa
|
DOVE, SIMON
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$440,000
|
Cystic Fibrosis
|
2015
|
NIGMS
|
5R01GM105691-02
|
|
MegaTALS: hyperspecific reagents for targeted gene modification and correction
|
STODDARD, BARRY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$334,400
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL105487-05
|
|
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
|
ROWE, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$446,920
|
Cystic Fibrosis
|
2015
|
NIEHS
|
5R21ES023384-02
|
|
Fungal Exposure and the Respiratory Tract Microbiome
|
EVANS, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$310,500
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL118000-02
|
|
Mining a microRNA Regulated Gene Network to Rescue CFTR-DeltaF508 Function
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$472,131
|
Cystic Fibrosis
|
2015
|
NIGMS
|
5R01GM108492-02
|
|
Dynamics of Bacterial-Fungal Interactions in Chronic Lung Infections
|
HOGAN, DEBORAH
|
DARTMOUTH COLLEGE
|
NH
|
$358,734
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1K01HL125514-01
|
|
SPLUNC1 and Neutrophilic Inflammation in Cystic Fibrosis
|
BRITTO-LEON, CLEMENTE
|
YALE UNIVERSITY
|
CT
|
$138,915
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5K01DK090195-05
|
|
Characterization of the ER associated Biogenesis and Degradation of ENaC
|
BUCK, TERESA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$99,446
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5K08HL107142-05
|
|
Chloride secretagogues for acquired CFTR dysfunction in chronic rhinosinusitis
|
WOODWORTH, BRADFORD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$133,596
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI091699-04
|
|
Mechanism of Cif Virulence: A Bacterial Strategy to Subvert Host-Cell Defenses
|
MADDEN, DEAN
|
DARTMOUTH COLLEGE
|
NH
|
$457,132
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R15AI111210-01A1
|
|
Decoding P. aeruginosa RIP cascade and discovering its inhibitors as therapeutics
|
MATHEE, KALAI
|
FLORIDA INTERNATIONAL UNIVERSITY
|
FL
|
$421,190
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R15HL126122-01
|
|
Identifying Bacterial Biomarkers Associated with Disease Progression in Cystic Fibrosis
|
STECK, TODD
|
UNIVERSITY OF NORTH CAROLINA CHARLOTTE
|
NC
|
$453,000
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI095338-04
|
|
The Role of Hepoxilin A3 in Neutrophil Breach of the Infected Airway Mucosa
|
HURLEY, BRYAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$439,285
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK051870-18
|
|
Restoration of mutant CFTR stability and function
|
RIORDAN, JOHN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$445,200
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2R01HL080396-07A1
|
|
Role of Mucin in Lung Homeostasis and Pathophysiology
|
EVANS, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$402,107
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI097264-03
|
|
Post-transcriptional regulation of Pseudomonas virulence gene expression
|
YAHR, TIMOTHY
|
UNIVERSITY OF IOWA
|
IA
|
$360,896
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R21AI112029-01A1
|
|
Nitric oxide-releasing cystic fibrosis therapeutics
|
SCHOENFISCH, MARK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$218,721
|
Cystic Fibrosis
|
2015
|
NIAID
|
1K99AI108787-01A1
|
|
Dissection of Complex Multifactorial Interactions between Bacterial Species.
|
KHARE, ANUPAMA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$132,300
|
Cystic Fibrosis
|
2015
|
NEI
|
2R01EY011221-17
|
|
Significance of Corneal Cell Invasion By Bacteria
|
FLEISZIG, SUZANNE
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$391,771
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK048816-17
|
|
CFTR and acid-base transporters in regenerating intestinal crypts
|
CLARKE, LANE
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$357,174
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL108927-04
|
|
SPLUNC1-Derived Peptides as ENaC Antagonists
|
TARRAN, ROBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$357,878
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL112863-04
|
|
Th2 inflammation promotes airway surface liquid dehydration
|
MYERBURG, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$373,068
|
Cystic Fibrosis
|
2015
|
NIDCD
|
5R01DC012377-04
|
|
Proteomic networks of MUC5B infectious/inflammatory induction in Otitis Media
|
PRECIADO, DIEGO
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$442,606
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL117836-03
|
|
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia
|
OSTROWSKI, LAWRENCE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$374,300
|
Cystic Fibrosis
|
2015
|
NCATS
|
1R13HL126239-01
|
|
2015 Cilia, Mucus and Mucociliary Interactions Gordon Research Conference
|
BRODY, STEVEN
|
GORDON RESEARCH CONFERENCES
|
RI
|
$5,000
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R13HL126239-01
|
|
2015 Cilia, Mucus and Mucociliary Interactions Gordon Research Conference
|
BRODY, STEVEN
|
GORDON RESEARCH CONFERENCES
|
RI
|
$20,000
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R13HL126239-01
|
|
2015 Cilia, Mucus and Mucociliary Interactions Gordon Research Conference
|
BRODY, STEVEN
|
GORDON RESEARCH CONFERENCES
|
RI
|
$5,000
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI103341-03
|
|
Mucosal Immunization Against P. aeruginosa by Modified Adenovirus Vectors
|
WORGALL, STEFAN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$423,750
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI103369-03
|
|
Integration of redox-balancing mechanisms in Pseudomonas aeruginosa biofilms
|
DIETRICH, LARS
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$395,942
|
Cystic Fibrosis
|
2015
|
NIGMS
|
1R43GM113510-01
|
|
Stable and Tunable Episomes for Gene Therapy
|
VAN DEN HEUVEL, PIETER
|
VIRONIKA, LLC
|
PA
|
$130,000
|
Cystic Fibrosis
|
2015
|
NINDS
|
1F31NS087747-01A1
|
|
Antisense-oligonucleotide-directed inhibition of nonsense-mediated mRNA decay
|
NOMAKUCHI, TOMOKI
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$27,120
|
Cystic Fibrosis
|
2015
|
NICHD
|
1F31HD080320-01A1
|
|
Mechanisms of inflammation in cystic fibrosis and potential for reversibility
|
HENDERSON, LEIGH
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$36,720
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK096096-03
|
|
CFTR modulates innate immune response in the biliary epithelium. Role in the path
|
STRAZZABOSCO, MARIO
|
YALE UNIVERSITY
|
CT
|
$362,138
|
Cystic Fibrosis
|
2015
|
NIGMS
|
5SC3GM098173-04
|
|
A Protein Synthesis System from Pseudomonas aeruginosa for Screening for Antibact
|
BULLARD, JAMES
|
UNIVERSITY OF TEXAS RIO GRANDE VALLEY
|
TX
|
$107,700
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK055835-15
|
|
Molecular Pathophysiology of Cystic Fibrosis
|
HWANG, TZYH-CHANG
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$353,050
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK068196-10
|
|
Chaperone Actions in CFTR Biogenesis
|
FRIZZELL, RAYMOND
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$342,650
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK095738-04
|
|
Baby Observational and Nutritional Study of Cystic Fibrosis
|
RAMSEY, BONNIE
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$413,603
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5K99HL119560-02
|
|
Neural Pathogenesis of Airway Smooth Muscle Defects in Airway Disease
|
REZNIKOV, LEAH
|
UNIVERSITY OF IOWA
|
IA
|
$97,200
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI097380-04
|
|
Pharmacodynamic modeling of antibiotics on cystic fibrosis P. aeruginosa biofilms
|
YANG, KATHERINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$388,286
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R21DK100783-02
|
|
Role of Blood Flow and Vascular Function on Exercise Capacity in Cystic Fibrosis
|
HARRIS, RYAN
|
GEORGIA REGENTS UNIVERSITY
|
GA
|
$189,792
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK083284-05
|
|
Regulated biosynthesis and function of ABC-transport systems
|
THIBODEAU, PATRICK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$329,513
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL110873-04
|
7489
|
Dynamics and Thermal Stability in CFTR Function and Dysfunction
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$363,717
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL110873-04
|
7490
|
: CFTR-ENaC Regulatory and Structural Interactions in Human Airway Epithelia
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$405,152
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL110873-04
|
7491
|
Purinergic Control of CFTR-ENaC Interactions in Alveolar Epithelia
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$486,820
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL110873-04
|
7494
|
Molecular Biology Core
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$215,946
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK044003-25
|
|
Molecular Genetics of Cystic Fibrosis
|
CUTTING, GARRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$405,000
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5K23HL103801-05
|
|
Use of Phosphodiesterase Inhibitors to Evaluate the Pathobiology of CF
|
TAYLOR-COUSAR, JENNIFER
|
NATIONAL JEWISH HEALTH
|
CO
|
$120,732
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5F30HL123239-02
|
|
Mechanisms Controlling Airway Surface Liquid pH
|
SHAH, VIRAL
|
UNIVERSITY OF IOWA
|
IA
|
$28,566
|
Cystic Fibrosis
|
2015
|
NIBIB
|
5R21EB017985-02
|
|
Novel Approach to Image Mucin Release and Swelling
|
GRYCZYNSKI, ZYGMUNT
|
TEXAS CHRISTIAN UNIVERSITY
|
TX
|
$163,977
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL117843-03
|
|
Mining open chromatin to define molecular mechanisms of CF modifier genes
|
HARRIS, ANN
|
LURIE CHILDREN'S HOSPITAL OF CHICAGO
|
IL
|
$574,864
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R37DK049835-20
|
|
DEVELOPMENT OF MEMBRANE PROTEIN STRUCTURE
|
THOMAS, PHILIP
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$364,266
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI113330-02
|
|
Resuscitation of P. aeruginosa biofilm cells from dormancy
|
FRANKLIN, MICHAEL
|
MONTANA STATE UNIVERSITY - BOZEMAN
|
MT
|
$324,000
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL071798-11
|
|
Pathogenesis of PCD Lung Disease
|
KNOWLES, MICHAEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$432,237
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL114447-04
|
|
Pulmonary bacterial microbiome-epithelial cell interactions in COPD
|
HUFFNAGLE, GARY
|
UNIVERSITY OF MICHIGAN
|
MI
|
$382,189
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI080609-07
|
|
Type VI secretion effectors and interbacterial competition in vivo
|
MOUGOUS, JOSEPH
|
UNIVERSITY OF WASHINGTON
|
WA
|
$488,116
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK097830-04
|
|
Evaluation of the entero-insular (incretin) axis in cystic fibrosis
|
KELLY, ANDREA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$480,125
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL108929-05
|
|
Imaging Airway Liquid Absorption in Cystic Fibrosis
|
CORCORAN, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$373,068
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI026289-27
|
|
Coordinate Regulation of Bacterial Virulence Factors
|
MEKALANOS, JOHN
|
HARVARD MEDICAL SCHOOL
|
MA
|
$538,137
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5P30DK072482-09
|
7869
|
Cell Model & Assay Core
|
KIRK, KEVIN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$232,435
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5P30DK072482-09
|
7870
|
Animal Models Core
|
BEDWELL, DAVID
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$325,230
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5P30DK072482-09
|
7871
|
Clinical and Translational Core
|
ROWE, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$193,380
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5P30DK072482-09
|
7872
|
Pilot and Feasibility Program
|
SORSCHER, ERIC
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$219,750
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI113219-02
|
|
Characterization of Biofilms by Correlated Mass Spectrometric and Raman Imaging
|
SHROUT, JOSHUA
|
UNIVERSITY OF NOTRE DAME
|
IN
|
$445,455
|
Cystic Fibrosis
|
2015
|
NIAID
|
5K08AI102921-03
|
|
Mechanisms to restrain social cheating from quorum sensing in Pseudomonas aerugin
|
DANDEKAR, AJAI
|
UNIVERSITY OF WASHINGTON
|
WA
|
$175,792
|
Cystic Fibrosis
|
2015
|
NIMHD
|
1R43MD010177-01A1
|
|
Cystic Fibrosis Remote monitoring System to Support Resource-Limited Communities
|
LICHTER, PATRICK
|
KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT
|
MN
|
$195,693
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL126603-01
|
|
Contribution of neutrophils to early airway disease in cystic fibrosis children
|
TIROUVANZIAM, RABINDRA
|
EMORY UNIVERSITY
|
GA
|
$350,489
|
Cystic Fibrosis
|
2015
|
NIGMS
|
5R01GM097414-04
|
|
Molecular Mechanism of Translocon Assembly into Cell Plasma Membranes
|
HEUCK, ALEJANDRO
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$297,589
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R37AI083256-07
|
|
cdiGMP regulation of Biofilm Formation
|
O'TOOLE, GEORGE
|
DARTMOUTH COLLEGE
|
NH
|
$400,847
|
Cystic Fibrosis
|
2015
|
NIDDK
|
1R01DK104681-01
|
|
Activating cystic fibrosis transmembrance conductance regulator: the therapeutic potential of RNA directed gene activation
|
MORRIS, KEVIN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$413,735
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5K08HL105466-05
|
|
Novel Pathways of Inflammation and Biofilm Regulation in the Lung
|
WILLIAMS, BRYAN
|
UNIVERSITY OF MINNESOTA
|
MN
|
$137,160
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI095307-04
|
|
Alternative macrophage activation in acute Pseudomonas pneumonia
|
FEOLA, DAVID
|
UNIVERSITY OF KENTUCKY
|
KY
|
$361,308
|
Cystic Fibrosis
|
2015
|
NIGMS
|
1R01GM114234-01
|
|
Mechanism of Activation and Membrane Interactions of Pseudomonas toxin ExoU
|
FEIX, JIMMY
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$306,452
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL127413-01
|
|
Biodegradable Mucus Penetrating DNA Nanoparticle for Gene Therapy of CF
|
HANES, JUSTIN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$412,141
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5K23HL105541-05
|
|
Cystic Fibrosis as a Model of Health Care Transition for Chronically Ill Youth
|
SAWICKI, GREGORY
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$139,174
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL108808-04
|
5919
|
The Biophysics of Mucus Hydration and Adhesion/Cohesion
|
RUBINSTEIN, MICHAEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$376,771
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL108808-04
|
5920
|
Mucus Obstructed Mice for Biomarker and Drug Development
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$480,885
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL108808-04
|
5921
|
Targeting Defective Mucus Clearance in COPD
|
DONALDSON, SCOTT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$454,189
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL108808-04
|
5925
|
Pharmacokinetics/Pharmacodynamics (PK/PD) Core
|
GRUBB, BARBARA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$363,424
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL108808-04
|
5926
|
Compound/Combination Selection Core
|
BUTTON, BRIAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$274,429
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R03AI117069-01
|
|
Developing Obese Mouse Models of Pseudomonas Aeruginosa Pneumonia
|
WARGO, MATTHEW
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$77,000
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5U01HL114589-03
|
|
OPTIMIZE - DCC
|
HAMBLETT, NICOLE
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$585,079
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5U01HL114623-03
|
|
OPTIMIZE - CCC - Lead Application
|
RAMSEY, BONNIE
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$1,550,633
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R21AI109417-02
|
|
Glutamate-dependent behavior of Pseudomonas aeruginosa
|
SHROUT, JOSHUA
|
UNIVERSITY OF NOTRE DAME
|
IN
|
$190,000
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK077065-08
|
|
Functional Relevance of CFTR Trafficking In Vivo to Intestinal Disease
|
AMEEN, NADIA
|
YALE UNIVERSITY
|
CT
|
$362,138
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R21AI117131-01
|
|
The Pseudomonas aeruginosa protease CtpA and type 3 secretion
|
DARWIN, ANDREW
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$254,250
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI091702-05
|
|
Host-associated regulation of P. aeruginosa colonization and virulence
|
HOGAN, DEBORAH
|
DARTMOUTH COLLEGE
|
NH
|
$395,000
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R33AI098802-04
|
|
Small Molecule Inhibitors of P. aeruginosa Quinolone (Pqs) Quorum Sensing
|
TAN, DEREK
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$496,535
|
Cystic Fibrosis
|
2015
|
NINDS
|
1R21NS091941-01
|
|
New tools for computing macro and microscopic channel properties from structure
|
ROSENBERG, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$246,193
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R34HL127166-01
|
|
A Pilot Study of the Effect of the CFTR Potentiator Ivacaftor in COPD (P-TOPIC)
|
ROWE, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$296,969
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R21AI117333-01
|
|
Intrabodies that prevent or disrupt biofilms
|
KAZMIERCZAK, BARBARA
|
YALE UNIVERSITY
|
CT
|
$249,749
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK089507-06
|
7669
|
Administrative Core
|
RAMSEY, BONNIE
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$128,748
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK089507-06
|
7670
|
Microbiology Core
|
GREENBERG, EVERETT
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$162,537
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK089507-06
|
7671
|
Genomics Core
|
MILLER, SAMUEL
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$149,865
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK089507-06
|
7672
|
Host Response Core
|
FREVERT, CHARLES
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$168,780
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK089507-06
|
7673
|
Clinical Core
|
GOSS, CHRISTOPHER
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$220,175
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK089507-06
|
7674
|
Pilot and Feasibility Program
|
SINGH, PRADEEP
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$395,415
|
Cystic Fibrosis
|
2015
|
NIAID
|
5F32AI098307-03
|
|
C. elegans immune defense against the P. aeruginosa toxin Exotoxin A
|
MCEWAN, DEBORAH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$57,962
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI101307-04
|
|
Investigating treatment resistance mechanisms in chronic bacterial infections
|
SINGH, PRADEEP
|
UNIVERSITY OF WASHINGTON
|
WA
|
$594,236
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL113548-04
|
|
Method Development for Survival Dynamic Regression in Chronic Disease Research
|
PENG, LIMIN
|
EMORY UNIVERSITY
|
GA
|
$304,834
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK054759-16
|
7715
|
Administrative Core
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$110,455
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK054759-16
|
7716
|
Vector Core
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$166,100
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK054759-16
|
7717
|
Animal Models Core
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$264,440
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK054759-16
|
7718
|
Comparative Pathology Core
|
GIBSON-CORLEY, KATHERINE
|
UNIVERSITY OF IOWA
|
IA
|
$120,800
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK054759-16
|
7719
|
Cells and Tissue Core
|
ZABNER, JOSEPH
|
UNIVERSITY OF IOWA
|
IA
|
$166,100
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK054759-16
|
7720
|
Clinical Core
|
STARNER, TIMOTHY
|
UNIVERSITY OF IOWA
|
IA
|
$90,600
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK054759-16
|
7721
|
Pilot and Feasibility
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$214,005
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK065988-11
|
7746
|
Administrative Core
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$190,000
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK065988-11
|
7747
|
Pre-Clinical Core
|
GENTZSCH, MARTINA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$190,000
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK065988-11
|
7748
|
Cell Models Core
|
RANDELL, SCOTT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$190,000
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK065988-11
|
7749
|
Mucus Biochemistry and Biophysics Core
|
BUTTON, BRIAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$190,000
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK065988-11
|
7750
|
Clinical Translation Core
|
DONALDSON, SCOTT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$190,000
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK065988-11
|
7751
|
Pilot and Feasibility Program
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$189,998
|
Cystic Fibrosis
|
2015
|
NIDCD
|
5R01DC007903-09
|
|
Cytokine Inflammatory Mediators and Mucin Regulation in Middle Ear Epithelium
|
KERSCHNER, JOSEPH
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$320,665
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072506-11
|
7809
|
Administrative Core
|
FRIZZELL, RAYMOND
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$68,552
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072506-11
|
7810
|
Human Airway Cells and Assays
|
FRIZZELL, RAYMOND
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$434,842
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072506-11
|
7811
|
Translational Studies
|
PILEWSKI, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$185,635
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072506-11
|
7812
|
Imaging
|
WATKINS, SIMON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$123,228
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072506-11
|
7813
|
Pilot and Feasibility Overview
|
FRIZZELL, RAYMOND
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$17,217
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072506-11
|
7814
|
LMTK2 AND TGF BETA SIGNALING IN HUMAN AIRWAY EPITHELIAL CELLS
|
SWIATECKA-URBAN, AGNIESZKA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$115,500
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072506-11
|
7815
|
Alcorn Pilot
|
ALCORN, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$115,499
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK047757-21
|
7824
|
Administrative Core
|
WILSON, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$61,739
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK047757-21
|
7825
|
Core A - Vector Core
|
JOHNSTON, JULIE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$300,738
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK047757-21
|
7826
|
Core B - Immunology Core
|
CALCEDO, ROBERTO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$159,998
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK047757-21
|
7830
|
Pilot and Feasibility Program
|
LIMBERIS, MARIA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$172,026
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072517-11
|
7846
|
Administrative Core
|
VERKMAN, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$256,631
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072517-11
|
7847
|
High-Throughput Screening
|
VERKMAN, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$337,705
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072517-11
|
7848
|
Cell & Tissue Models
|
FINKBEINER, WALTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$204,579
|
Cystic Fibrosis
|
2015
|
NIDDK
|
2P30DK072517-11
|
7850
|
CF Cell & Tissue Bioassays
|
HAGGIE, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$129,449
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R01AI117064-01
|
|
Consortium for drug-resistant Gram-negative pathogen detection
|
RILEY, LEE
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$1,154,056
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL116226-04
|
|
MR predictors of infection, inflammation, and structural lung damage in CF
|
CLANCY, JOHN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$482,554
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL116228-04
|
|
Mucus and hypoxia in heterogeneous and progressive CF lung disease
|
MUHLEBACH, MARIANNE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$508,031
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL116232-04
|
|
The Lung Clearance Index as a Marker of Early Lung Disease in Preschool Children
|
RATJEN, FELIX
|
HOSPITAL FOR SICK CHLDRN (TORONTO)
|
CANADA
|
$431,307
|
Cystic Fibrosis
|
2015
|
RMAP
|
5R01HL117328-04
|
|
Geobiological approaches to understanding pulmonary infections in situ
|
NEWMAN, DIANNE
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$412,500
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R00HL114862-04
|
|
Spatial characterization of microbial communities in the cystic fibrosis lung
|
HUNTER, RYAN
|
UNIVERSITY OF MINNESOTA
|
MN
|
$236,509
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL116211-04
|
|
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
|
DAVIS, STEPHANIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$531,756
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL116235-04
|
|
Microbiome acquistion and the progression of inflammation and airway disease in i
|
KAZMIERCZAK, BARBARA
|
YALE UNIVERSITY
|
CT
|
$608,835
|
Cystic Fibrosis
|
2015
|
NIGMS
|
2R01GM051329-17A1
|
|
Structure, Assembly, and Function of Outer Membrane Proteins
|
TAMM, LUKAS
|
UNIVERSITY OF VIRGINIA
|
VA
|
$439,910
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL122372-01A1
|
|
Regional Hypoxia Impacts the Heterogeneity of Inflammatory Lung Disease
|
ASHARE, ALIX
|
DARTMOUTH COLLEGE
|
NH
|
$457,701
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK101541-02
|
|
Preclinical development of CFTR stabilizers targeting the CAL PDZ domain
|
MADDEN, DEAN
|
DARTMOUTH COLLEGE
|
NH
|
$171,128
|
Cystic Fibrosis
|
2015
|
NIGMS
|
5R01DK101541-02
|
|
Preclinical development of CFTR stabilizers targeting the CAL PDZ domain
|
MADDEN, DEAN
|
DARTMOUTH COLLEGE
|
NH
|
$280,000
|
Cystic Fibrosis
|
2015
|
NHLBI
|
7R01HL047125-22
|
|
Mechanism of anti-inflammatory role of MUC1 during airway bacterial infection
|
KIM, KWANG
|
UNIVERSITY OF ARIZONA
|
AZ
|
$389,897
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL116213-04
|
|
Functional Anatomic Imaging of CF Patients with Early Lung Disease Using microOCT
|
ROWE, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$498,330
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL091842-08
|
8785
|
Mucociliary transport in early cystic fibrosis lung disease
|
WELSH, MICHAEL
|
UNIVERSITY OF IOWA
|
IA
|
$342,996
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL091842-08
|
8786
|
Respiratory virus infection in early cystic fibrosis lung disease
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$342,996
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL091842-08
|
8787
|
Airway pH and antimocrobial activity in early cystic fibrosis
|
ZABNER, JOSEPH
|
UNIVERSITY OF IOWA
|
IA
|
$342,996
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL091842-08
|
8788
|
Animal Core
|
STOLTZ, DAVID
|
UNIVERSITY OF IOWA
|
IA
|
$795,837
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5P01HL091842-08
|
8790
|
Imaging Core
|
STOLTZ, DAVID
|
UNIVERSITY OF IOWA
|
IA
|
$199,547
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL123771-01A1
|
|
Viral-bacterial co-infections in the lung
|
BOMBERGER, JENNIFER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$374,904
|
Cystic Fibrosis
|
2015
|
NIBIB
|
5F31EB018707-02
|
|
Engineering human iPS cells into an airway epithelium capable of ion transport
|
ZAIDMAN, NATHAN
|
UNIVERSITY OF MINNESOTA
|
MN
|
$29,440
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL124053-01A1
|
|
A prospective trial of oral azithromycin when added to inhaled tobramycin in CF
|
NICHOLS, DAVID
|
NATIONAL JEWISH HEALTH
|
CO
|
$817,198
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R24DK096518-04
|
|
Early Pathogenesis of Cystic Fibrosis Related Diabetes
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$1,497,916
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL125076-01A1
|
|
Phagosomal Ion Channels as Therapeutic Targets
|
NELSON, DEBORAH
|
UNIVERSITY OF CHICAGO
|
IL
|
$499,131
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI077628-06
|
|
The pel exopolysaccharide gene cluster of Pseudomonas aeruginosa
|
PARSEK, MATTHEW
|
UNIVERSITY OF WASHINGTON
|
WA
|
$484,019
|
Cystic Fibrosis
|
2015
|
NIAID
|
1K08AI108792-01A1
|
|
Burkholderia-mediated defective killing mechanisms in macrophages from cystic fibrosis (CF) patients
|
KOPP, BENJAMIN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$150,912
|
Cystic Fibrosis
|
2015
|
NIDDK
|
1K23DK102600-01A1
|
|
The Endocrine Complications of Cystic Fibrosis: the Role of CFTR
|
PUTMAN, MELISSA
|
CHILDREN'S HOSPITAL CORPORATION
|
MA
|
$152,781
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R42AI098192-03
|
|
Anti-biofilm agents for the treatment of pulmonary infection in cystic fibrosis p
|
POLLARD, ANGELA
|
AGILE SCIENCES, INC.
|
NC
|
$826,326
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5K01DK102851-02
|
|
Integration of Nutritional Metabolomics with Bioenergetics in Cystic Fibrosis
|
ALVAREZ, JESSICA
|
EMORY UNIVERSITY
|
GA
|
$107,149
|
Cystic Fibrosis
|
2015
|
NICHD
|
5R01HD068901-05
|
|
Transcriptional Networks Regulating Luminal Environment in the Epididymis
|
HARRIS, ANN
|
LURIE CHILDREN'S HOSPITAL OF CHICAGO
|
IL
|
$286,650
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R44HL114299-03
|
|
Novel molecular therapeutics for cystic fibrosis
|
STERNER, DAVID
|
PROGENRA, INC.
|
PA
|
$667,073
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK072126-10
|
|
Newborn Screening, Malnutrition and Lung Disease in Children with Cystic Fibrosis
|
LAI, HUICHUAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$598,452
|
Cystic Fibrosis
|
2015
|
NIGMS
|
5P30GM106394-03
|
8599
|
LIVE-CELL IMAGING CORE
|
STANTON, BRUCE
|
DARTMOUTH COLLEGE
|
NH
|
$150,798
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL119337-02
|
|
Exercise Hyperemia in Humans
|
JOYNER, MICHAEL
|
MAYO CLINIC ROCHESTER
|
MN
|
$738,627
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R21AI109385-02
|
|
Targeting P. aeruginosa penicillin-binding proteins for drug discovery
|
DAVIES, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$186,875
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL095524-06
|
|
Epigenomic Modulation of Cystic Fibrosis
|
BALCH, WILLIAM
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$466,643
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R21HL120770-02
|
|
Functional Genetics in Idiopathic Pulmonary Fibrosis
|
SCHWARTZ, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$210,402
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R01HL123535-02
|
|
Characterization of an inhibitory protein complex for cystic fibrosis therapy
|
ZHANG, WEIQIANG
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$373,467
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1F30HL124925-01A1
|
|
The Role of the EHF Transcription Factor in Lung Epithelial Function
|
FOSSUM, SARA
|
LURIE CHILDREN'S HOSPITAL OF CHICAGO
|
IL
|
$34,874
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5U01DK084536-07
|
|
Continuation of ChiLDReN, the Childhood Liver Disease Research Network: Indiana U
|
MOLLESTON, JEAN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$339,939
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1F31HL128116-01
|
|
An investigation into the CFTR-Associated Ligand (CAL) and the underlying molecular mechanism by which it increases cell surface expression of ΔF508-CFTR through regulation of trafficking pathways
|
BERGBOWER, EMILY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$43,120
|
Cystic Fibrosis
|
2015
|
NIGMS
|
5F31GM109729-02
|
|
Theta Defensins For Targeting The Metalloproteinase System in CF Airway Disease
|
BENSMAN, TIMOTHY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$41,430
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R21AI103651-02
|
|
Mechanism of Phosphorylcholination of EF-Tu on Pseudomonas aeruginosa
|
GOLDBERG, JOANNA
|
EMORY UNIVERSITY
|
GA
|
$192,900
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5F30DK097872-03
|
|
Defining a mechanism for altered PUFA metabolism in cystic fibrosis
|
UMUNAKWE, OBINNA
|
VANDERBILT UNIVERSITY
|
TN
|
$46,210
|
Cystic Fibrosis
|
2015
|
NIDCR
|
5K08DE021413-06
|
|
Investigation of CFTR on sinus and craniofacial development in a CF porcine
|
CHANG, EUGENE
|
UNIVERSITY OF ARIZONA
|
AZ
|
$121,041
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK097820-04
|
|
Fatty Acid Defects & Oxidative Stress Modulate Islet Function in Cystic Fibrosis
|
UC, ALIYE
|
UNIVERSITY OF IOWA
|
IA
|
$377,500
|
Cystic Fibrosis
|
2015
|
RMAP
|
5K01GM103809-04
|
|
The Interactive Metabolome of Polymicrobial Biofilms
|
PHELAN, VANESSA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$130,092
|
Cystic Fibrosis
|
2015
|
NIAID
|
5R01AI076272-07
|
|
Studies on the Pseudomonas aeruginosa Cell-to-Cell Signal PQS
|
PESCI, EVERETT
|
EAST CAROLINA UNIVERSITY
|
NC
|
$376,323
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R24HL123482-02
|
|
National Ferret Resource and Research Center on Lung Disease
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$832,691
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK097829-04
|
|
Islet Biology in Cystic Fibrosis Related Diabetes
|
AGUILAR-BRYAN, LYDIA
|
PACIFIC NORTHWEST RESEARCH INSTITUTE
|
WA
|
$577,260
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5K08HL124298-02
|
|
Re-establishment of directional mucociliary transport after epithelial injury
|
VINARSKY, VLADIMIR
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$137,087
|
Cystic Fibrosis
|
2015
|
NIDDK
|
5R01DK095869-02
|
|
The relationship of fecal microbiomes and nutritional status in CF
|
HOFFMAN, LUCAS
|
UNIVERSITY OF WASHINGTON
|
WA
|
$645,802
|
Cystic Fibrosis
|
2015
|
NEI
|
5R01EY016144-11
|
|
Pathogenesis of microbial anterior eye diseases
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$416,677
|
Cystic Fibrosis
|
2015
|
NCATS
|
5U54HL096458-12
|
|
Genetic Disorder of Mucocilary Clearance
|
KNOWLES, MICHAEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$937,500
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5U54HL096458-12
|
|
Genetic Disorder of Mucocilary Clearance
|
KNOWLES, MICHAEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$308,233
|
Cystic Fibrosis
|
2015
|
NICHD
|
5R21HD078121-02
|
|
Modulation of neonatal alveolar macrophage by cftr mutation
|
GAUTHIER, THERESA
|
EMORY UNIVERSITY
|
GA
|
$190,125
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5UH2HL123442-02
|
|
MUC5B, a novel therapeutic target for Idiopathic Pulmonary Fibrosis (IPF)
|
SCHWARTZ, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$1,461,675
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5UH2HL123645-02
|
|
Synthesis of Effective and Safe Mucolytics for Pulmonary Disease
|
BOUCHER, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$1,424,781
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2P01HL051670-21A1
|
8351
|
Gene Therapy For Cystic Fibrosis Lung Disease - Administration Core
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$52,676
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2P01HL051670-21A1
|
8352
|
Core A: Animal Models
|
STOLTZ, DAVID
|
UNIVERSITY OF IOWA
|
IA
|
$813,635
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2P01HL051670-21A1
|
8353
|
Core B: Gene Transfer Vector Core
|
SINN, PATRICK
|
UNIVERSITY OF IOWA
|
IA
|
$166,100
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2P01HL051670-21A1
|
8354
|
Core C: In Vitro Models and Cell Culture
|
ZABNER, JOSEPH
|
UNIVERSITY OF IOWA
|
IA
|
$181,200
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2P01HL051670-21A1
|
8355
|
Core D: Pathology Core
|
MEYERHOLZ, DAVID
|
UNIVERSITY OF IOWA
|
IA
|
$71,725
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2P01HL051670-21A1
|
8356
|
Gene Transfer to Porcine Respiratory Epithelia with Viral Vectors
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$310,100
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2P01HL051670-21A1
|
8357
|
Transgenic Approaches to Understand the Biology of Airway Gene Transfer
|
WELSH, MICHAEL
|
UNIVERSITY OF IOWA
|
IA
|
$310,382
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2P01HL051670-21A1
|
8358
|
Gene Therapy for Lung Disease in a Ferret Model of Cystic Fibrosis
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$311,060
|
Cystic Fibrosis
|
2015
|
NIAID
|
3R01AI080609-06A1S1
|
|
Type VI secretion effectors and interbacterial competition in vivo
|
MOUGOUS, JOSEPH
|
UNIVERSITY OF WASHINGTON
|
WA
|
$16,521
|
Cystic Fibrosis
|
2015
|
NIEHS
|
1K23ES025781-01
|
|
Indoor air pollution, mucociliary clearance, and mucus properties in COPD
|
PAULIN, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$166,518
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R21AI119043-01
|
|
Countering beta-lactam resistance in Pseudomonas aeruginosa
|
JIN, SHOUGUANG
|
UNIVERSITY OF FLORIDA
|
FL
|
$264,747
|
Cystic Fibrosis
|
2015
|
NIBIB
|
1R21EB020849-01
|
|
3D assessment of airway liquid absorption and muco-ciliary transport: key markers of lung disease pathophysiology
|
VENEGAS, JOSE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$264,369
|
Cystic Fibrosis
|
2015
|
NIDDK
|
1R01DK101402-01A1
|
|
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients
|
MORAN, ANTOINETTE
|
UNIVERSITY OF MINNESOTA
|
MN
|
$717,323
|
Cystic Fibrosis
|
2015
|
NIGMS
|
1R01GM111329-01A1
|
|
Chemical and Biological Optimization of a Gram negative Selective Antibiotic
|
DE BRABANDER, JEF
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$238,861
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL125892-01A1
|
|
Targeted correction of the human CFTR gene
|
EGAN, MARIE
|
YALE UNIVERSITY
|
CT
|
$554,851
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL125280-01A1
|
|
The role of mucus and pulmonary surface interactions in lung defense
|
BUTTON, BRIAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$377,740
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL125520-01A1
|
|
Explanatory models of CF Survival, Infection and Intermediate Clinical Outcomes
|
LIOU, THEODORE
|
UNIVERSITY OF UTAH
|
UT
|
$350,151
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2K24HL102246-06
|
|
Studies on bacterial populations and therapeutics for CF lung infections
|
SINGH, PRADEEP
|
UNIVERSITY OF WASHINGTON
|
WA
|
$150,206
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1K25HL125954-01A1
|
|
Preventing rapid decline in CF: statistical research career commitment
|
SZCZESNIAK, RHONDA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$145,587
|
Cystic Fibrosis
|
2015
|
NHLBI
|
2R01HL074175-10A1
|
|
Role of Virulence Factors in Pseudomonas-Host Interactions
|
STANTON, BRUCE
|
DARTMOUTH COLLEGE
|
NH
|
$405,000
|
Cystic Fibrosis
|
2015
|
NIAMS
|
1R03AR068724-01
|
|
A novel bacterial protease and its involvement in wound infection
|
KUSMIERCZYK, ANDREW
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$76,136
|
Cystic Fibrosis
|
2015
|
NIAID
|
3R01AI103369-03S1
|
|
Integration of redox-balancing mechanisms in Pseudomonas aeruginosa biofilms
|
DIETRICH, LARS
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$51,253
|
Cystic Fibrosis
|
2015
|
NIDDK
|
1R43DK107004-01
|
|
Prevention and treatment of GI obstruction syndromes in cystic fibrosis
|
BAKER, SHENDA
|
SYNEDGEN, INC.
|
CA
|
$146,412
|
Cystic Fibrosis
|
2015
|
NIAID
|
1R43AI120375-01
|
|
Antibiotic potentiators maximizing the formation of open- channel OprF-type outer membrane porins
|
MOIR, DONALD
|
MICROBIOTIX, INC
|
MA
|
$282,826
|
Cystic Fibrosis
|
2015
|
NIDCR
|
1F30DE024917-01A1
|
|
The Role of Salivary Mucin in Preventing Cariogenic Streptococcus Biofilm Formation
|
SHAPIRO, ERICA
|
HARVARD MEDICAL SCHOOL
|
MA
|
$40,520
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1F32HL129815-01
|
|
Treatment of Persistent MRSA Infection in Cystic Fibrosis Patients
|
DEZUBE, REBECCA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$78,066
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1F31HL126458-01A1
|
|
A novel microRNA in pulmonary fibrosis
|
STOLZENBURG, LINDSAY
|
LURIE CHILDREN'S HOSPITAL OF CHICAGO
|
IL
|
$36,799
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL129795-01
|
|
Controlling the core airway mucin secretion machinery to prevent pathophysiology
|
DICKEY, BURTON
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$400,000
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL127651-01A1
|
|
The role of microRNA-calibrated autophagy in innate immunity and inflammation
|
AMER, AMAL
|
OHIO STATE UNIVERSITY
|
OH
|
$386,967
|
Cystic Fibrosis
|
2015
|
NHLBI
|
5R44HL112393-04
|
|
Development of Inhaled Vancomycin for Treatment of MRSA Infections in CF
|
JOUHIKAINEN, TANELI
|
SAVARA, INC.
|
TX
|
$1,015,080
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R01HL129925-01
|
|
Defining the Pulmonary Attributes of Pre-symptomatic Lung Disease in Cystic Fibrosis
|
LAUBE, BETH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$315,000
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1R21HL129930-01
|
|
Pseudomonas Genomic Signatures Associated With Persistence in Cystic Fibrosis
|
HAUSER, ALAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$207,914
|
Cystic Fibrosis
|
2015
|
NIAID
|
4R33AI105980-03
|
|
Gene silencing therapeutics for chronic infections in cystic fibrosis
|
GREENBERG, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$367,923
|
Cystic Fibrosis
|
2015
|
NIDDK
|
1K23DK107937-01
|
|
Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance
|
SHEIKH, SABA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$121,342
|
Cystic Fibrosis
|
2015
|
NIDDK
|
3R24DK096518-04S1
|
|
Early Pathogenesis of Cystic Fibrosis Related Diabetes
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$13,590
|
Cystic Fibrosis
|
2015
|
NIDDK
|
3R01DK097829-03S1
|
|
Islet Biology in Cystic Fibrosis Related Diabetes
|
AGUILAR-BRYAN, LYDIA
|
PACIFIC NORTHWEST RESEARCH INSTITUTE
|
WA
|
$18,840
|
Cystic Fibrosis
|
2015
|
NIDDK
|
1R56DK107489-01
|
|
Probing adenylate kinase-dependent CFTR gating in vivo and as therapeutic target
|
RANDAK, CHRISTOPH
|
UNIVERSITY OF IOWA
|
IA
|
$173,938
|
Cystic Fibrosis
|
2015
|
NIDDK
|
1R56DK109692-01
|
|
Early Childhood Diet, Growth, Gut Microbiome and Lung Health in Cystic Fibrosis
|
LAI, HUICHUAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$150,355
|
Cystic Fibrosis
|
2015
|
NHGRI
|
1ZIAHG200323-11
|
|
Genomic, Epigenetic and Functional Analyses of Vertebrate Regulatory Regions
|
ELNITSKI, LAURA
|
NIH
|
|
$1,578,827
|
Cystic Fibrosis
|
2015
|
NHLBI
|
1ZIAHL006200-01
|
|
Bronchiectasis and chronic airway infection
|
OLIVIER, KENNETH
|
NIH
|
|
$1,482,875
|
|